Update: kardiovaskuläre Schlafmedizin

Atemstörungen im Schlaf kommen bei Herzpatienten häufig vor – z. T. ohne die klassischen Symptome. Häufig weisen sie jedoch internistische Symptome auf, die bislang therapieresistent waren. Die Polygrafie hilft hier, Risikopatienten zu identifizieren. Neben Verhaltensregeln zählen Beatmungsmaßnahmen zu den Therapieoptionen, so z. B. CPAP bei OSA und Herzinsuffizienz. Bei ZSA und Herzinsuffizienz ist die adaptive Servoventilation nicht empfohlen.

• Literatur

• 1 Linz D, Woehrle H, Bitter T. et al. The importance of sleep-disordered breathing in cardiovascular disease. Clin Res Cardiol 2015; 104: 705-718
• 2 Linz D, Arzt M. Schlafstörungen und Herzerkrankungen. Dtsch Med Wochenschr 2015; 140: 1272-1277
• 3 Schäfer H, Hasper E, Ewig S. et al. Schlafbezogene Atmungsstörungen: Etabliertes und Neues in Diagnostik und Therapie. Dtsch Arztebl 1996; 93: A-2396/B-2046/C-1919
• 4 Kasai T, Bradley TD. Obstructive sleep apnea and heart failure: pathophysiologic and therapeutic implications. J Am Coll Cardiol 2011; 11: 119-127
• 5 Linz D, Linz B, Hohl M. et al. Atrial arrhythmogenesis in obstructive sleep apnea: Therapeutic implications. Sleep Med Rev 2016; 26: 87-94
• 6 Linz D, Hohl M, Ukena C. et al. Obstructive respiratory events and premature atrial contractions after cardioversion. Eur Respir J 2015; 45: 1332-1340
• 7 Linz D, Mahfoud F, Linz B. et al. Effect of obstructive respiratory events on blood pressure and renal perfusion in a pig model for sleep apnea. Am J Hypertens 2014; 27: 1293-1300
• 8 Javaheri S, Dempsey JA. Central sleep apnea. Compr Physiol 2013; 3: 141-163
• 9 White LH, Bradley TD. Role of nocturnal rostral fluid shift in the pathogenesis of obstructive and central sleep apnoea. J Physiol 2013; 591: 1179-1193
• 10 Hall MJ, Xie A, Rutherford R. et al. Cycle length of periodic breathing in patients with and without heart failure. Am J Respir Crit Care Med 1996; 154: 376-381
• 11 Oldenburg O, Arzt M, Bitter T. et al. Positionspapier „Schlafmedizin in der Kardiologie“ Update 2014. Kardiologe 2015; 9: 140-158
• 12 Becker HF, Ficker J, Fietze I. et al. S3-Leitlinie Nicht erholsamer Schlaf/Schlafstörungen. Somnologie 2009; 13: 4-160
• 13 Arzt M, Young T, Finn L. et al. Sleepiness and sleep in patients with both systolic heart failure and obstructive sleep apnea. Arch Intern Med 2006; 166: 1716-1722
• 14 Mancia G, Fagard R, Narkiewicz K. et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013; 34: 2159-2219
• 15 Fein AS, Shvilkin A, Shah D. et al. Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence after catheter ablation. J Am Coll Cardiol 2013; 62: 300-305
• 16 Kirchhof P, Benussi S, Kotecha D. et al. ESC Scientific Document Group. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 2016; 37: 2893-2962 doi:10.1093/eurheartj/ehw210
• 17 Kuniyoshi FH, Garcia-Touchard A, Gami AS. et al. Day-night variation of acute myocardial infarction in obstructive sleep apnea. J Am Coll Cardiol 2008; 52: 343-346
• 18 Buchner S, Satzl A, Debl K. et al. Impact of sleep-disordered breathing on myocardial salvage and infarct size in patients with acute myocardial infarction. Eur Heart J 2014; 35: 192-199
• 19 McEvoy RD, Antic NA, Heeley E. et al. SAVE Investigators and Coordinators. CPAP for Prevention of Cardiovascular Events in Obstructive Sleep Apnea. N Engl J Med 2016; 375: 919-931
• 20 Arzt M, Woehrle H, Oldenburg O. et al. SchlaHF Investigators. Prevalence and Predictors of Sleep-Disordered Breathing in Patients With Stable Chronic Heart Failure: The SchlaHF Registry. JACC Heart Fail 2016; 4: 116-125
• 21 Oldenburg O, Faber L, Vogt J. et al. Influence of cardiac resynchronisation therapy on different types of sleep disordered breathing. Eur J Heart Fail 2007; 9: 820-826
• 22 Bradley TD, Logan AG, Kimoff RJ. et al. CANPAP Investigators. Continuous positive airway pressure for central sleep apnea and heart failure. N Engl J Med 2005; 353: 2025-2033
• 23 Arzt M, Floras JS, Logan AG. et al. CANPAP Investigators. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation 2007; 115: 3173-3180
• 24 Cowie MR, Woehrle H, Wegscheider K. et al. Adaptive servoventilation for central sleep apnea in systolic heart failure. N Engl J Med 2015; 373: 1095-1105
• 25 Ponikowski P, Voors AA, Anker SD. et al. ESC Scientific Document Group. 2016. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016; 37: 2129-2200
• 26 Linz D, Fox H, Bitter T. et al. Impact of SERVE-HF on management of sleep disordered breathing in heart failure: a call for further studies. Clin Res Cardiol 2016; 105: 563-570
• 27 Herrscher TE, Akre H, Øverland B. et al. High prevalence of sleep apnea in heart failure outpatients: even in patients with preserved systolic function. J Card Fail 2011; 17: 420-425
• 28 Ewen S, Nikolovska A, Zivanovic I. et al. Chronische Herzinsuffizienz – neue Erkenntnisse. Dtsch Med Wochenschr 2016; 141: 1560-1564